Clinical Trials Directory

Trials / Completed

CompletedNCT02865447

Evaluation of Bone Mineral Density Changes After Total Hip Replacement: A Two-Year Clinical and DXA Analysis

A Dual Energy X-ray Absorptiometry (DXA) Evaluation of Bone Density Changes After Hip Replacement. Performance of the PROFEMUR® PRESERVE Hip Stem in Total Hip Arthroplasty, Two-Year Clinical and DXA Analysis

Status
Completed
Phase
Study type
Observational
Enrollment
25 (actual)
Sponsor
MicroPort Orthopedics Inc. · Industry
Sex
All
Age
21 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Sponsor is conducting this post-market study to evaluate the clinical outcome and femoral bone mineral density (BMD) changes associated with the PROFEMUR® PRESERVE hip stem when used as indicated for primary total hip arthroplasty in patients with osteoarthritis of the hip joint.

Conditions

Interventions

TypeNameDescription
DEVICEtotal hip arthroplasty implantPROFEMUR PRESERVE total hip arthroplasty femoral stem

Timeline

Start date
2017-03-09
Primary completion
2020-08-24
Completion
2020-08-24
First posted
2016-08-12
Last updated
2022-08-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02865447. Inclusion in this directory is not an endorsement.

Evaluation of Bone Mineral Density Changes After Total Hip Replacement: A Two-Year Clinical and DXA Analysis (NCT02865447) · Clinical Trials Directory